13F filer · CIK 1778253
Ikarian Capital, LLC
DALLAS, TX · filing since Q4 2019 · last filing Aug 14, 2026
Reported value
$928.2M
$-303.5M vs prior
Positions
156
New / sold out
41 / 46
Added / reduced
24 / 33
Turnover
32.5%
buys $350.6M · sells $725.7M
Top-10 weight
37.0%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | ABIVAX SA | +271,000 | +470.2% | +$35.7M |
| New | ABIVAX SAPUT | +250,000 | – | +$33.3M |
| New | MODERNA INCPUT | +400,000 | – | +$28.0M |
| New | IONIS PHARMACEUTICALS INCPUT | +300,000 | – | +$23.8M |
| Added | IONIS PHARMACEUTICALS INCCALL | +287,900 | +256.8% | +$22.8M |
| New | ARCUS BIOSCIENCES INC | +504,559 | – | +$15.6M |
| New | COGENT BIOSCIENCES INC | +370,084 | – | +$14.3M |
| New | NEWAMSTERDAM PHARMA COMPANYPUT | +400,000 | – | +$13.6M |
| New | C4 THERAPEUTICS INC | +2,433,000 | – | +$11.4M |
| Added | ANI PHARMACEUTICALS INC | +125,000 | +85.0% | +$10.3M |
55 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | SPDR SERIES TRUSTPUT | -500,000 | -62.5% | $-79.1M |
| Sold out | TERNS PHARMACEUTICALS INC | -1,456,378 | -100.0% | $-76.8M |
| Sold out | TERNS PHARMACEUTICALS INCPUT | -1,200,000 | -100.0% | $-63.3M |
| Sold out | INVESCO QQQ TRPUT | -100,000 | -100.0% | $-57.7M |
| Sold out | ISHARES TRPUT | -200,000 | -100.0% | $-49.6M |
| Sold out | CYTOKINETICS INCPUT | -550,500 | -100.0% | $-36.3M |
| Sold out | CYTOKINETICS INCCALL | -408,400 | -100.0% | $-26.9M |
| Reduced | BRISTOL-MYERS SQUIBB COPUT | -457,500 | -91.5% | $-26.4M |
| Sold out | CYTOKINETICS INC | -283,572 | -100.0% | $-18.7M |
| Reduced | HARROW INC | -407,272 | -75.0% | $-17.3M |
69 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | SPDR SERIES TRUSTPUTST STR SP BIOT | 300,000 | $47.5M | 5.11% |
| 2 | ABIVAX SACALLSPONSORED ADS | 341,100 | $45.5M | 4.90% |
| 3 | ABIVAX SASPONSORED ADS | 328,635 | $43.4M | 4.67% |
| 4 | KODIAK SCIENCES INCCOM | 1,059,730 | $41.3M | 4.45% |
| 5 | ABIVAX SAPUTSPONSORED ADS | 250,000 | $33.3M | 3.59% |
| 6 | IONIS PHARMACEUTICALS INCCALLCOM | 400,000 | $31.7M | 3.42% |
| 7 | MODERNA INCPUTCOM | 400,000 | $28.0M | 3.02% |
| 8 | ALUMIS INCCOM | 870,548 | $24.5M | 2.64% |
| 9 | PRAXIS PRECISION MEDICINES ICOM NEW | 72,842 | $24.4M | 2.63% |
| 10 | IONIS PHARMACEUTICALS INCPUTCOM | 300,000 | $23.8M | 2.56% |
146 more rows. Subscribe for $29/month to see every row, download the data and use the API.